272 related articles for article (PubMed ID: 37864642)
1. Neurological Complications Associated with Hereditary Bleeding Disorders.
Bhatti MQ; Gonzalez-Fernandez E; Bhatia K; Divani AA; Di Napoli M; Hinduja A; Datta YH
Curr Neurol Neurosci Rep; 2023 Nov; 23(11):751-767. PubMed ID: 37864642
[TBL] [Abstract][Full Text] [Related]
2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literature.
Shanmukhaiah C; Jijina F; Kannan S; Pai NG; Kulkarni B; Khuba SV; Shaikh M; Joshi A; Phatale R; Apte S
Haemophilia; 2022 Mar; 28(2):286-291. PubMed ID: 35014121
[TBL] [Abstract][Full Text] [Related]
6. Hemophilia and von Willebrand Disease: A Review of Emergency Department Management.
Tebo C; Gibson C; Mazer-Amirshahi M
J Emerg Med; 2020 May; 58(5):756-766. PubMed ID: 32249010
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.
Pacheco LD; Saade GR; James AH
Obstet Gynecol; 2023 Mar; 141(3):493-504. PubMed ID: 36800851
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
Abshire T; Cox-Gill J; Kempton CL; Leebeek FW; Carcao M; Kouides P; Donfield S; Berntorp E
J Thromb Haemost; 2015 Sep; 13(9):1585-9. PubMed ID: 25930155
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes.
Siegmund B; Richter H; Pollmann H
Haemophilia; 2007 Jan; 13(1):21-5. PubMed ID: 17212720
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Berntorp E
Semin Thromb Hemost; 2006 Sep; 32(6):621-5. PubMed ID: 16977572
[TBL] [Abstract][Full Text] [Related]
11. Translating the success of prophylaxis in haemophilia to von Willebrand disease.
Miesbach W; Berntorp E
Thromb Res; 2021 Mar; 199():67-74. PubMed ID: 33445035
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive care for hemophilia and other inherited bleeding disorders.
Page D
Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
[TBL] [Abstract][Full Text] [Related]
13. Hemophilia A and von Willebrand deficiency: therapeutic implications.
Basso M; Lazzareschi I; Curatola A; Di Gennaro L; Buonsenso D; Gatto A; De Candia E; De Cristofaro R
Blood Coagul Fibrinolysis; 2020 Sep; 31(6):397-401. PubMed ID: 32255574
[TBL] [Abstract][Full Text] [Related]
14. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in Patients With Hemophilia and von Willebrand Disease Undergoing Invasive or Surgical Procedures.
Chapin J; Bamme J; Hsu F; Christos P; DeSancho M
Clin Appl Thromb Hemost; 2017 Mar; 23(2):148-154. PubMed ID: 27418638
[TBL] [Abstract][Full Text] [Related]
16. Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A.
Rodeghiero F; Castaman G; Mannucci PM
Thromb Haemost; 1996 Nov; 76(5):692-6. PubMed ID: 8950775
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature.
Thomas VM; Abou-Ismail MY; Lim MY
Haemophilia; 2022 Jan; 28(1):4-17. PubMed ID: 34820989
[TBL] [Abstract][Full Text] [Related]
18. Emergency department care for patients with hemophilia and von Willebrand disease.
Singleton T; Kruse-Jarres R; Leissinger C
J Emerg Med; 2010 Aug; 39(2):158-65. PubMed ID: 18757163
[TBL] [Abstract][Full Text] [Related]
19. Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
Olasupo OO; Noronha N; Lowe MS; Ansel D; Bhatt M; Matino D
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD014544. PubMed ID: 38411279
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
